Indication
Oral candidiasis
Oral candidiasis is an opportunistic fungal infection of the oral cavity and mucous membranes caused by an overgrowth of *Candida* species, predominantly *Candida albicans*. Read more about Oral candidiasis
84 drugs 72 manufacturers
Drugs that treat it
Common Oral candidiasis therapies.
NYSTATIN
FLUCONAZOLE
FLUCONAZOLE
FLUCONAZOLE
NYSTATIN
FLUCONAZOLE
FLUCONAZOLE-NACL (fluconazole in sodium chloride, iso-osmotic)
FLUCONAZOLE-NACL (fluconazole in sodium chloride, iso-osmotic)
News & literature
Coming soonRelated codes
Coming soonRelated conditions & guidelines
Coming soonOral candidiasis is an opportunistic fungal infection of the oral cavity and mucous membranes caused by an overgrowth of *Candida* species, predominantly *Candida albicans*.
It commonly affects neonates, older adults, denture wearers, and individuals with local or systemic immunosuppression, including patients using inhaled corticosteroids or broad-spectrum antibiotics, as well as those with diabetes mellitus or HIV/AIDS.
Pathophysiologically, the condition occurs when disruptions in mucosal barrier integrity, salivary flow, or host immune defenses allow commensal yeasts to transform into invasive hyphal forms.
Clinical presentations typically manifest as wipeable white pseudomembranous plaques over an erythematous base, burning erythematous mucosal lesions, or chronic hyperplastic plaques, often accompanied by oral pain, altered taste, or dysphagia.
- nih.gov
Oral candidiasis is an opportunistic fungal infection of the oral cavity and mucous membranes caused by an overgrowth of *Candida* species, predominantly *Candida albicans* Clinical presentations typically manifest as wipeable white pseudomembranous plaques over an erythematous base, burning erythematous mucosal lesions, or chronic hyperplastic plaques, often accompanied by oral pain, altered taste, or dysphagia
- nih.gov
Oral candidiasis is an opportunistic fungal infection of the oral cavity and mucous membranes caused by an overgrowth of *Candida* species, predominantly *Candida albicans* It commonly affects neonates, older adults, denture wearers, and individuals with local or systemic immunosuppression, including patients using inhaled corticosteroids or broad-spectrum antibiotics, as well as those with diabetes mellitus or HIV/AIDS Pathophysiologically, the condition occurs when disruptions in mucosal barri...
- nih.gov
It commonly affects neonates, older adults, denture wearers, and individuals with local or systemic immunosuppression, including patients using inhaled corticosteroids or broad-spectrum antibiotics, as well as those with diabetes mellitus or HIV/AIDS
- nih.gov
It commonly affects neonates, older adults, denture wearers, and individuals with local or systemic immunosuppression, including patients using inhaled corticosteroids or broad-spectrum antibiotics, as well as those with diabetes mellitus or HIV/AIDS
- nih.gov
Pathophysiologically, the condition occurs when disruptions in mucosal barrier integrity, salivary flow, or host immune defenses allow commensal yeasts to transform into invasive hyphal forms
- cyberderm.net
Pathophysiologically, the condition occurs when disruptions in mucosal barrier integrity, salivary flow, or host immune defenses allow commensal yeasts to transform into invasive hyphal forms Clinical presentations typically manifest as wipeable white pseudomembranous plaques over an erythematous base, burning erythematous mucosal lesions, or chronic hyperplastic plaques, often accompanied by oral pain, altered taste, or dysphagia
Personalize your experience
Follow Oral candidiasis and get updates as they land.
Already a member? Sign in
Follow an indication and get alerts when its drugs, labels, or guidelines change
Save any drug on this page to your favorites, synced across devices
AI-curated peer-reviewed research, summarized for your specialty
A morning digest of indication-relevant updates, when you want it
Sign in to follow this indication
Following an indication requires a free Physicians Office Resource account.